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Ion channels regulate many aspects of cell physiology, includ-
ing cell proliferation, motility, and migration, and aberrant
expression and activity of ion channels is associated with various
stages of tumor development, with K and Cl channels now
being considered the most active during tumorigenesis. Accord-
ingly, emerging in vitro and preclinical studies have revealed
that pharmacological manipulation of ion channel activity
offers protection against several cancers. Merkel cell polyoma-
virus (MCPyV) is a major cause of Merkel cell carcinoma (MCC),
primarily because of the expression of two early regulatory pro-
teins termed small and large tumor antigens (ST and LT, respec-
tively). Several molecular mechanisms have been attributed to
MCPyV-mediated cancer formation but, thus far, no studies
have investigated any potential link to cellular ion channels.
Here we demonstrate that Cl channel modulation can reduce
MCPyV ST-induced cell motility and invasiveness. Proteomic
analysis revealed that MCPyV ST up-regulates two Cl chan-
nels, CLIC1 and CLIC4, which when silenced, inhibit MCPyV
ST-induced motility and invasiveness, implicating their func-
tion as critical to MCPyV-induced metastatic processes. Con-
sistent with these data, we confirmed that CLIC1 and CLIC4 are
up-regulated in primary MCPyV-positive MCC patient samples.
We therefore, for the first time, implicate cellular ion channels
as a key host cell factor contributing to virus-mediated cellular
transformation. Given the intense interest in ion channel mod-
ulating drugs for human disease. This highlights CLIC1 and
CLIC4 activity as potential targets for MCPyV-induced MCC.
During virus-induced transformation, alterations in the bio-
logical properties of infected cells by viral oncogenes confers
properties that can drive tumor progression (1). The subversion
of several host pathways has been linked to the oncogenic abil-
ity of viral proteins, but the modulation of host cell ion channel
activity and the contribution of this important virus– host
interaction to viral oncogenesis has not been studied. Ion chan-
nels regulate many aspects of cell physiology, including cell pro-
liferation, motility, and migration, making them an attractive
target for viral manipulation (2, 3). The aberrant expression and
activity of ion channels is associated with various stages of
tumor development, and emerging in vitro and preclinical stud-
ies have revealed that pharmacological manipulation of ion
channel activity offers protection against several cancers (4).
Merkel cell carcinoma (MCC)4 is a highly aggressive neuroen-
docrine carcinoma of the skin. MCC is characterized by the
appearance of local or regional lymph nodes with a high pro-
pensity for distant metastases in various sites (5). Accordingly,
MCC has a poor 5-year survival rate. The reported cases of
MCC have tripled in the last 20 years in both Europe and the
United States, because of an increase in associated risk factors,
including UV exposure, immunosuppression, and increased
age (6).
In 2008, Merkel cell polyomavirus (MCPyV) was identified to
be clonally integrated in 80% of MCC tumors (7). Like other
polyomaviruses, MCPyV expresses a variety of early spliced
variant regulatory proteins required for viral replication and
pathogenesis, including the small and large tumor antigens (ST
and LT, respectively) (8). MCPyV infection and integration
appear to occur prior to tumor cell expansion, with additional
truncated LT mutations observed which render MCPyV repli-
cation defective (7). Notably, depletion studies have demon-
strated that both ST and LT protein are required for MCC
survival and proliferation (9). However, in contrast to other
polyomaviruses, MCPyV ST is sufficient to transform rodent
cells to anchorage- and contact-independent growth and also
induces serum-free proliferation of human cells (10). Recent
studies have explored the contribution of MCPyV ST to MCC
development and proliferation, suggesting it is highly multi-
functional. MCPyV ST functions as an inhibitor of NF-B–
mediated transcription (11) and leads to the hyperphosphory-
lation of the translation regulatory protein, 4E-BP1, resulting in
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motes transcriptional changes in glycolytic metabolic pathways
(12). Moreover, MCPyV ST prevents SCFFwb7-mediated degra-
dation of MCPyV LT and several cellular oncoproteins (13).
MCPyV ST also promotes differential expression of cellular
proteins involved in microtubule and actin-associated cytoskel-
etal organization and dynamics, which leads to a motile and
migratory phenotype (14, 15). Notably, this MCPyV ST-in-
duced migratory phenotype may be associated with the highly
metastatic nature of MCC tumors. This is also supported by
recent studies showing that engraftment of MCC cell lines into
SCID mice results in circulating tumor cells and metastasis for-
mation (16).
We demonstrate herein that two members of the chloride
channel family, a diverse group of anion selective channels, are
up-regulated by MCPyV ST to induce motility and invasiveness
during MCPyV-induced metastasis. This for the first time
implicates cellular ion channels as a contributing factor to
virus-mediated cellular transformation.
Results
Cl channel modulators inhibit MCPyV ST-induced cell
motility
Viral proteins modulate cellular ion channel functionality to
favor their life cycles (2). In recent years, Cl channels have
emerged as some of the most active cellular ion channels during
tumorigenesis, because of their involvement in both cell motil-
ity and proliferation (17, 18). We reasoned that Cl channels
could therefore play a role in MCPyV ST-induced cell motility.
If so, Cl channel blockers, including diisothiocyanostilbene-
2,20-disulfonic acid (DIDS), 5-nitro-2–3-phenylpropylamino
benzoic acid (NPPB), and R()-indyanyloxyacetic acid 94
(RIAA) (3) would be predicted to affect MCPyV ST-induced
cell motility. This was investigated in two independent cell lines
under conditions of MCPyV ST expression. i293-EGFP and
i293-EGFP-ST cells were induced using doxycycline hyclate
(14), whereas MCC13 cells (an MCPyV-negative Merkel carci-
noma cell line) were transfected with enhanced GFP (EGFP) or
EGFP-ST, and treated with each respective inhibitor for 24 h.
Cell motility was assessed through IncuCyte imaging, every 30
min for 24 h and the distance traveled by individual cells
tracked using ImageJ. Fig. 1, A and B shows that MCPyV ST-
expressing cells displayed larger average distances traveled
(1.7-fold increase in motility in ST-expressing cells, n  25, p 
0.001) indicative of enhanced cell motility in both cell lines,
consistent with previous findings (14). Fig. 1, A and B also dem-
onstrates that, upon the addition of DIDS, NPPB, and RIAA, no
significant differences were observed between the average dis-
tances traveled by control GFP-expressing cells, but the motil-
ity of MCPyV ST-expressing cells significantly decreased fol-
lowing drug treatments in both cell types (reduced to baseline
motility, n  25, p  0.001). The effects of the drugs were not
additive when combined, and validated as nontoxic at the con-
centrations assessed by MTS assay (Fig. S1). The effects of
DIDS, NPPB, and RIAA were reversible, as when the drugs were
washed from the cells for 24 h, a significant recovery of cell
motility was observed most notably in MCPyV ST expressing
MCC13 cells (Fig. 1, A and B(iii), n  25, p  0.001).
To further confirm these effects, haptotaxis migration assays
were performed in the presence of DIDS, NPPB, and RIAA.
This assay investigates the three-dimensional migration of cells
toward a chemoattractant across a permeable chamber.
Induced i293-EGFP and i293-EGFP-ST cells were transferred
to haptotaxis plates and treated with DIDS, NPPB, and RIAA.
Cells were allowed to migrate for 24 h and migration was
assessed by immunofluorescent staining of cells that had
migrated into the chambers. Fig. 1C shows that i293-EGFP-ST
cells displayed enhanced migration compared with control
(n  3, p  0.001), which was significantly reduced by treat-
ment with DIDS, NPPB, and RIAA, suggesting that MCPyV
ST-induced migration is similarly Cl channel dependent.
Together these data suggest that cellular Cl channels are
involved in MCPyV ST-induced cell motility and migration,
and thus may contribute to MCPyV ST-induced metastatic
processes.
MCPyV ST enhances the expression of CLIC1 and CLIC4
We next investigated the identity of the Cl channel(s)
required by MCPyV ST to enhance cell motility and migration.
Approximately 40 genes encode proteins classified as Clintra-
cellular-channel (CLIC) proteins, cyclic AMP– gated (CFTR),
calcium-activated (CaCC), voltage-activated Cl channels and
Cl/H exchangers (CLCs), as well as ligand-gated Cl chan-
nels (GABAA, GABAC, and glycine) (19). We re-analyzed our
previous quantitative proteomic datasets to determine poten-
tial alterations in the host cell channelome on inducible
MCPyV ST expression (14). Analysis revealed that MCPyV ST
expression up-regulates the expression of two CLIC family pro-
teins CLIC1 (Fig. 2A, 5.67-fold increase of ST/control cells) and
CLIC4 (Fig. 2A, 4.39-fold increase of ST/control cells). To con-
firm these datasets, we assessed the levels of CLIC1 and CLIC4
expression upon MCPyV ST induction by immunoblotting cell
lysates obtained from induced i293-EGFP and i293-EGFP-ST
cells and MCC13 cells transfected with EGFP or EGFP-ST for
48 h. Fig. 2B shows that both CLIC1 and CLIC4 were up-regu-
lated upon MCPyV ST expression in both cell lines, confirming
their up-regulation (Fig. 2, B and C). This increase in CLIC1/
CLIC4 levels occurred at the protein level, as transcription lev-
els assessed by RT-quantitative PCR remained relatively un-
changed in both cell types (Fig. 2D). The increase in expression
was reflected by an increase in the cell surface expression of
CLIC1 and CLIC4 in i293-EGFP-ST cells compared with EGFP
control, assessed using surface biotinylation assays (Fig. 2E(i
and ii)). This was not a global effect on cell surface protein
expression levels because the levels of transferrin receptor
(CD71) were unaffected by MCPyV ST (Fig. 2E(i and ii)).
Together these data confirm that CLIC1 and CLIC4 are up-reg-
ulated upon MCPyV ST expression.
Depletion of CLIC1 and CLIC4 disrupts MCPyV ST-induced cell
motility
Because of the increased expression of CLIC1 and CLIC4 in
MCPyV ST-expressing cell lines, we investigated the effects of
CLIC1/CLIC4 silencing on MCPyV ST-induced cell motility.
Induced i293-EGFP and i293-EGFP-ST cells or MCC13 cells
transfected with EGFP or EGFP-ST were transfected with
MCPyV ST enhances Cl channels for cell motility























CLIC1- and/or CLIC4-specific siRNA. CLIC1/CLIC4 depletion
both as single and double knockdowns was confirmed via
immunoblotting (Fig. 3, A (i) and B(i)). When the motility of
MCPyV ST-expressing i293 and MCC13 cells was assessed in
CLIC1/CLIC4 silenced cells (IncuCyte kinetic, cells imaged
every 30 min for 24 h), significant decreases in the average dis-
tances traveled were observed compared with scrambled
siRNA controls, most notably in MCPyV ST MCC13 cells
(return to baseline motility, n  25, p  0.001) (Fig. 3, A (ii) and
B(ii)). Interestingly, differences in the average distance traveled
for non-MCPyV ST-expressing cells following knockdown of
CLIC1 and/or CLIC4 were not observed, suggesting they
only contribute to the enhanced motility observed following
MCPyV ST expression (Fig. 3, A–C) (n  25). To confirm that
the enhanced motility observed in MCPyV ST-expressing cells
is because of CLIC1/4 overexpression we performed gain-of-
function experiments to assess the effect of CLIC1 overexpres-
sion in non-MCPyV ST-expressing 293 cells. Motility of EGFP-
Figure 1. Cl channel blockers inhibit the metastatic phenotypic changes associated with ST expression. A and B, in (A) i293-EGFP and i293-EGFP-ST cells
were induced with doxycycline hyclate and in (B) MCC13 cells were transfected with EGFP and EGFP-ST. (i) cells were then treated with DMSO, DIDS, RIAA, or
NPPB and after 24 h, cell motility was measured using the IncuCyte kinetic imaging system. Images were taken every 30 min for a 24-h period. (ii) scatter plot
showing cell movement tracked using ImageJ (n  25). Average cell movement, as indicated by the horizontal bar, was calculated and significance tested using
a two-tailed Student’s t test; *, p  0.001. (iii) After 24 h, inhibitors were washed off cells and media added. Cells were imaged for a further 24 h and average
movement calculated (n  25); *, p  0.001. C, i293-EGFP and i293-EGFP-ST cells were induced and treated with DMSO, DIDS, RIAA, or NPPB. After 24 h, cells
were transferred into migration wells and inhibitors added at appropriate concentrations to allow cells to migrate from serum-free to 10% FBS conditions for
24 h. Migratory cells were stained and measured at 560 nm to quantify migration. Average cell migration was calculated and significance tested using a
two-tailed Student’s t test (n  3); *, p  0.001.
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CLIC1– expressing cells (IncuCyte kinetic, cells imaged every
30 min for 24 h) displayed a significant increase in cell motility
over GFP control cells (Fig. 4A) (n  25, p  0.001) consistent
with CLIC1 induction leading to an enhanced motile pheno-
type. We also observed enhanced phosphorylation of ERK1/2
and NF-B p65 subunit following CLIC1 overexpression (Fig.
4B), the activation of which has been shown to enhance motility
in a range of cancers (20, 21). Activation of these signaling path-
ways may therefore contribute to the metastatic phenotype
observed following CLIC1 overexpression.
Furthermore, to demonstrate that the enhanced Cl chan-
nel activity is required for cell motility and migration of
MCPyV-positive MCC cell lines, haptotaxis migration assays
were performed in the presence of NPPB at nontoxic
concentrations assessed by MTS assay (Fig. S2), or upon
siRNA-mediated CLIC1 depletion, using two MCPyV-posi-
tive MCC cell lines. Cells were allowed to migrate for 24 h
and migration was assessed by immunofluorescent staining
of cells that had migrated into the chambers. Fig. 4C shows
that migration of MCPyV-positive MCC cell lines were sig-
nificantly reduced compared with control (n  3, p  0.001),
upon treatment with either NPPB or CLIC1 depletion, sug-
gesting that MCPyV-positive MCC cell line migration is sim-
ilarly Cl channel dependent. Together these data demon-
strate that CLIC1 or CLIC4 depletion specifically inhibits
MCPyV ST–induced motility, suggesting that these Cl
channels mediate the effects observed for pharmacological
Cl channel modulation.
Figure 2. MCPyV ST up-regulates CLIC proteins. A, quantitative proteomic analysis shows an increase in CLIC family protein levels upon MCPyV ST expres-
sion. B, i293-EGFP or i293-EGFPST cells were incubated for 48 h in the presence of doxycycline, whereas MCC13 cells were transfected with EGFP or EGFP-ST for
24 h. Cell lysates were probed using CLIC1- and CLIC4-specific antibodies. GAPDH and  actin were used to ensure equal loading. The 2T2 hybridoma was used
to probe for MCPyV ST expression. C, densitometry was performed using ImageJ (n  3) for (i) i293 or (ii) MCC13 samples. *, p  0.01. D, total RNA was extracted
from induced i293-EGFP or i293-EGFP-ST cells, reverse transcribed, and RT-quantitative PCR performed. Transcript levels were analyzed using the comparative
CT method (n  3). *, p  0.01. E, (i) surface biotinylation experiments were performed in induced i293-EGFP or i293-EGFP-ST cells; lysates were probed for
CLIC1, CLIC4, and CD71 as a surface marker control. (ii) densitometry of Western blots was performed using ImageJ software (n  3). *, p  0.01.
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MCPyV-positive MCC tumors overexpress CLIC1 and CLIC4
Finally, we assessed whether CLIC1 and CLIC4 are expressed
and/or up-regulated in MCC tumors. Immunoblotting analysis
was performed on cellular lysates of two independent MCPyV-
positive MCC tumor samples (MCC#1 and #2) comparing pro-
tein levels against a negative non-tumor cadaveric skin sample.
Fig. 5A(i) and resulting densitometry analysis (Fig. 5A(ii)) show
that CLIC1 and CLIC4 expression is enhanced in both MCC
samples compared with healthy skin. To further investigate the
differential expression of CLIC proteins in the context of MCC,
multicolor immunochemistry analysis was performed on for-
malin-fixed, paraffin-embedded (FFPE) sections of primary
MCPyV-positive MCC tumors distinct from the tumor samples
used above (MCC#3 and #4). Sections were incubated with
antibodies specific for CLIC1 and cytokeratin 20 (CK20), a
marker widely used to distinguish MCC and MCPyV LT (Fig.
5B). An isotype-matched control was also used as a negative
control. Results confirmed increased levels of CLIC1 coinci-
dent with CK20 in regions of the tumor.
Finally, to determine whether CLIC1 and CLIC4 are signifi-
cantly increased in MCPyV-positive MCC compared with
MCPyV-negative MCC, gene expression profiles for a total of
94 patients were obtained from a publicly available dataset
(accession number GSE39612 (22)). Expression profiles were
preprocessed, including background correction, normaliza-
tion, and summation of the intensities for each sample using
R/Bioconductor (23) and the R limma package used to call dif-
ferentially expressed genes (24). Strikingly, we identified a sig-
nificant increase in CLIC1 (2.5-fold, p  0.02) and CLIC4 (3.5-
fold, p  0.002) in MCPyV-positive MCC compared with
Figure 3. CLIC1 and CLIC4 KD inhibits MCPyV ST-induced cell motility. A and B, in A(i) i293-EGFP and i293-EGFP-ST cell lysates or (B)(i) EGFP or EGFP-ST-
transfected MCC13 cells were probed for successful knockdown with CLIC1- and CLIC4-specific antibodies. GAPDH was used as loading control and 2T2
hybridoma was used to show MCPyV ST expression. A(ii), i293-EGFP and i293-EGFP-ST cells were transfected with scrambled or CLIC1 and/or CLIC4 siRNA for
12 h, then induced using doxycycline for 24 h. B(ii), MCC13 cells were transfected with scrambled or CLIC1 and/or CLIC4 siRNA for 12 h, then retransfected with
EGFP and EGFP-ST after a further 12 h. 48 h post knockdown, cell motility was measured using the IncuCyte kinetic imaging system. Images were taken every
30 min for a 24-h period. C, scatter plots showing cell movement of (i) i293 or (ii) MCC13 cells tracked using ImageJ (n  25). Average cell movement, indicated
by horizontal bar, was calculated and significance was tested using a two-tailed Student’s t test. *, p  0.001.
MCPyV ST enhances Cl channels for cell motility























MCPyV-negative MCC control samples. Moreover, CLIC1
expression was also significantly increased (2.3-fold, p  0.04)
in metastatic MCPyV-positive MCC compared with a meta-
static MCPyV-negative MCC control, suggesting a link
between MCC MCPyV status and progression. Intriguingly,
several other chloride ion channels from the CLIC and CLCN
families were also dysregulated in a MCPyV-specific manner.
Together, these data support our in vitro observations and sug-
gest a link between MCPyV-mediated CLIC up-regulation and
MCC pathogenesis. Overall, these results confirm that CLIC1
and CLIC4 are up-regulated during MCPyV infection in vivo,
implicating a novel role for these channels in MCPyV-positive
MCC tumorigenesis.
Discussion
Growing evidence supports a role of cellular ion channels in
cancer development, but somewhat surprisingly, their contri-
bution to virus-induced cancer has yet to be documented. Cl
channels are considered one of the most active channel families
during neoplastic transformation as they control ion homeosta-
sis, pH levels, and cell volume, with the latter being particularly
important for cancer cell migration and infiltration. We sought
to assess the potential contribution of Cl channels to the met-
astatic processes that occur during MCPyV infection. We show
that MCPyV ST enhances the expression of CLIC1 and CLIC4
in transformed cell lines and primary MCC samples. When
these channels are silenced or pharmacologically inhibited,
MCPyV ST-induced motility is reduced. This, for the first time,
identifies cellular Cl channels that directly contribute to the
metastatic processes of a viral oncogene.
The dependence on CLIC1/CLIC4 during MCPyV ST meta-
static processes opens new insights into how viruses manipu-
late susceptible cells to mediate cancer progression. DNA
viruses can encode viroporins (25), a group of viral ion channel
proteins that participate in several viral functions, including the
promotion of release of virus particles, modulation of cellular
vesicles, and membrane permeability. MCPyV has no known
viroporin, suggesting it is likely that MCPyV proteins interfere
with the normal channelome to benefit virus replication. The
ability of MCPyV ST to specifically up-regulate CLIC1/CLIC4
promotes metastatic activities in virus-infected cells. This is
consistent with previous studies that identified the overexpres-
sion of CLIC1/CLIC4 in numerous cancer tissues including
colon, prostate, pancreatic, and ovarian (26 –28), suggesting
Figure 4. CLIC1 overexpression is required to induce cell motility in 293 and MCPyV-positive MCC cell lines. A, 293 cells were transfected with EGFP or
EGFP-CLIC1 for 24 h. (i) cell lysates were probed using CLIC1-specific antibody; GAPDH was used to ensure equal loading. (ii) scatter plot showing cell
movement tracked using ImageJ (n  25). Average cell movement, as indicated by the horizontal bar, was calculated and significance tested using a two-tailed
Student’s t test. *, p  0.001. B, 293 cells were transfected with EGFP or EGFP-CLIC1 for 24 h. Cell lysates were probed using CLIC1, ERK1/2, and NF-B–specific
antibodies; GAPDH was used to ensure equal loading. C, MCPyV-positive MCC cell lines, PeTa, and WAGA were (i) incubated with DMSO or NPPB or (ii)
transfected with scrambled or CLIC1 siRNA for 12 h. Cells were then transferred into migration wells and allowed to migrate from serum-free to 10% FBS
conditions for 24 h. Migratory cells were stained and measured at 560 nm to quantify migration. Average cell migration was calculated and significance tested
using a two-tailed Student’s t test (n  3). *, p  0.001. (iii) PeTa and WAGA cells were probed to confirm successful knockdown with CLIC1-specific antibodies.
GAPDH was used as loading control.
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they directly contribute to tumor development. Interestingly,
MCPyV-positive tumors were recently shown to display ele-
vated expression of GABRB3 and K channel genes at the tran-
scriptional level, which may play additional roles in the control
of ionic balance during tumor growth (29).
A key question remains, how does MCPyV ST target CLIC1
and CLIC4, and how does this ultimately benefit the virus? Both
channels are widely expressed and their activity regulates com-
ponents of the cytoskeleton, adhesion molecules, and cell sig-
naling pathways (18, 27, 30), all of which may contribute to
MCPyV ST tumor formation. We observed that the MCPyV ST
effects on CLIC1/CLIC4 did not occur at the transcriptional
level, ruling out the involvement of known MCPyV ST cellular
targets including p53 and tumor necrosis factor  (TNF) (31–
33) that regulate CLIC transcript levels. Others have estab-
lished that inducible NOS, through regulating channel nitrosy-
lation, can control the expression levels of CLICs through
protein degradation (34). Although the ability of MCPyV ST to
modulate inducible NOS has not been reported, it is currently
under investigation. Moreover, it is not known whether the
modified levels of CLIC1/CLIC4 mediate alterations in their
intracellular activity in cellular organelles, as the analysis of
channel functionality at these membranes is challenging. Thus,
although it can be concluded that MCPyV ST-induced CLIC1/
CLIC4 overexpression promotes a tumorigenic state, the
mechanisms behind this regulation and their molecular contri-
bution to MCC requires further investigation. It can be noted,
however, that MCPyV ST most likely exploits CLIC1 and
CLIC4 for a common cellular effect because simultaneous
silencing of the channels resulted in no synergistic inhibition of
MCPyV ST-induced cell motility. In addition, the observation
that CLIC1 overexpression can activate ERK1/2 and NF-B p65
raises the possibility that MCPyV ST targets CLIC1/CLIC4 to
regulate the mitogenic signaling pathways that contribute to
cancer metastasis (20, 21).
In conclusion, we reveal that MCPyV ST requires functional
CLIC1 and CLIC4 channels to promote cell motility and inva-
sion. To date, compounds specifically targeting CLIC1 and
CLIC4 are not clinically available, and no CLIC1/CLIC4 block-
ers have advanced into clinical trials. However, with the emerg-
ing interest in this ion channel family as an anti-cancer target,
inhibiting these channels may emerge as a novel therapeutic
approach for the treatment of MCC.
Experimental procedures
Mammalian cell culture
Inducible HEK-293-ST Flip-In cells, described previously
(11, 14), were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum and 1%
penicillin-streptomycin. MCC13, WAGA (9), and PeTa (35)
cells were maintained in RPMI 1640 media supplemented with
10% FBS and 1% penicillin-streptomycin.
Plasmids, siRNAs, and antibodies
EGFP-ST expression vectors have been described previously
(11). EGFP-CLIC1 expression construct was purchased from
OriGene. CLIC1- and CLIC4-specific siRNAs were purchased
from Qiagen (product no. 1027416). CLIC1 and CLIC4 anti-
Figure 5. CLIC1 and CLIC4 are up-regulated in MCC. A (i), healthy skin and two independent MCC biopsy samples (MCC#1 and MCC#2) were crushed using
a mortar and pestle on dry ice, lysed with RIPA buffer and then further homogenized by sonication. Tissue lysates were probed for CLIC1, CLIC4, GAPDH, and
2T2. (ii) densitometry of immunoblots was performed using ImageJ (n  3). *, p  0.001. B, formalin-fixed, paraffin-embedded (FFPE) sections from primary
MCC tumors (MCC#3 and MCC#4) were probed for (i) CK20 and CLIC1 and (ii) CK20 and MCPyV LT to demonstrate MCC sections were MCPyV positive. An
isotype-matched antibody was used as a negative control in parallel. Nuclei were counterstained with DAPI. Representative images captured with a Zeiss LSM
510 confocal microscope are shown.
MCPyV ST enhances Cl channels for cell motility























bodies were purchased from Santa Cruz Biotechnology (sc-
81873) and Abcam (ab76593), respectively. Antibodies were
used at 1:5000 dilution. The 2T2 hybridoma was provided by
Dr. Buck, National Cancer Institute, Bethesda, MD.
Cl channel modulators
RIAA (Sigma-Aldrich), NPPB (Tocris Bioscience), and DIDS
(Sigma-Aldrich) were used at the highest nontoxic concentra-
tions: 50, 25, and 50 M for HEK 293 cells, and 100, 50, 100 M
for MCC13 cells, respectively.
Immunoblotting
Skin and MCC tumor biopsy samples were crushed using a
pestle and mortar on dry ice and homogenized by sonication
prior to lysis in RIPA (50 mM Tris-HCl pH 7.6, 150 mM NaCl, 1%
Nonidet P-40), supplemented with protease inhibitor mixture
(Roche) as described previously (36). Proteins were separated
by SDS-PAGE, transferred to nitrocellulose membranes, and
probed with the appropriate primary and HRP-conjugated sec-
ondary antibodies, as described previously (37).
Live cell imaging
Cell motility was analyzed using IncuCyte kinetic live cell
imaging (14). Imaging was performed for 24 h, with images
taken every 30 min. Cell motility was tracked using ImageJ
software.
Haptotaxis migration assay
Migration assays were performed using CytoSelect 24-well
Haptotaxis Assay Collagen I coated plates (Cell Biolabs, Inc.), as
directed by the manufacturer.
Quantitative RT-PCR
RNA was extracted using TRIzol (Invitrogen) and DNase
treated as described previously (38). RNA concentration and
quality were compared using a NanoDrop 1000 spectropho-
tometer (NanoDrop Technologies) at 280 nm. RNA (1 g) from
each fraction was reverse transcribed with SuperScript II (Invit-
rogen) using oligo(dT) primers (Promega). mRNA quantitative
analysis was performed using the comparative CT method as
described previously (39). Primers used were as follows: CLIC1
(forward), GAC ACC TTC CAT CTT CAG CAC T; CLIC1
(reverse), CAA GAA TTC AAA CCC AGC ACT C; CLIC4 (for-
ward), CAT CCG TTT TGA CTT CAC TGT TG; CLIC4
(reverse), AGG AGT TGT ATT TAG TGT GAC GA.
Cell viability assays
Cell viability was assessed 24 h post treatment using the Cell-
Titer 96 AQueous One Solution Cell Proliferation Assay re-
agent (Promega) as described previously (40).
Multicolor immunohistochemistry
Formalin-fixed, paraffin-embedded (FFPE) sections from
primary MCC tumors were procured from OriGene and ana-
lyzed as described previously (41). Primary antibodies were
anti-CK20 (Dako Products, dilution 1:50), anti-CLIC1 and
-CLIC4 (Santa Cruz Biotechnology and Abcam, respectively,
dilution 1:250), and anti-MCPyV LT (Santa Cruz Biotechnol-
ogy, dilution 1:100). An isotype-matched irrelevant antibody
was used as a negative control on serial sections of tissues in
parallel.
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